Research Topics
Genomes and GenesSpecies | R PahwaSummaryAffiliation: University of Kansas Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Basic algorithms for the programming of deep brain stimulation in Parkinson's diseaseJens Volkmann
Department of Neurology, Christian Albrechts Universitat Kiel, Kiel, Germany
Mov Disord 21:S284-9. 2006..The basic programming algorithms for thalamic, subthalamic, and pallidal stimulation in PD are explained and summarized in flowcharts...
Prevalence of bone mineral density screening in Parkinson's disease clinic outpatientsMarty L Eng
Mov Disord 21:2265-6. 2006
Understanding Parkinson's disease: an update on current diagnostic and treatment strategiesRajesh Pahwa
J Am Med Dir Assoc 7:4-10. 2006..With chronic levodopa therapy, patients ultimately experience a wearing off in levodopa response and other motor complications. Management of wearing off is a significant challenge in the treatment of patients with advanced PD...
Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot studyRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA
Mov Disord 18:584-7. 2003..We conclude that the majority of the ET patients do not benefit from mirtazapine. Mirtazapine has significant adverse effects and should be used cautiously in ET patients...
Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single doseRajesh Pahwa
University of Kansas Medical Center, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
J Neurol Sci 258:137-43. 2007..To further explore the efficacy and safety of subcutaneous apomorphine (APO) in treating off episodes in APO-naïve patients with advanced Parkinson's disease (PD)...
Thalamic stimulation for midbrain tremor after partial hemangioma resectionRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Mov Disord 17:404-7. 2002..We describe a patient with disabling medication-resistant midbrain tremor developed after partial hemangioma resection, who responded to deep brain stimulation of the thalamus...
Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson diseaseR Pahwa
University of Kansas Medical Center, Kansas City, KS 66160, USA
Neurology 68:1108-15. 2007..To evaluate the efficacy of ropinirole 24-hour prolonged release (ropinirole 24-hour) as an adjunct to levodopa in patients with Parkinson disease (PD) and motor fluctuations...
Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow upRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Neurosurg 99:71-7. 2003..Bilateral subthalamic nucleus (STN) stimulation is increasingly used in patients with advanced Parkinson disease (PD). This study was performed to evaluate the long-term efficacy and safety of bilateral STN stimulation in cases of PD...
Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's diseaseRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Stereotact Funct Neurosurg 83:80-3. 2005..Younger age and a response to a supra-threshold levodopa challenge have been reported to predict a favorable response to bilateral subthalamic nucleus (STN) stimulation...
Ropinirole therapy for Parkinson's diseaseRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
Expert Rev Neurother 4:581-8. 2004..A once-daily formulation of ropinirole is currently in development that has the potential for greater convenience, improved tolerability and greater efficacy...
Essential tremor: differential diagnosis and current therapyRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160 7314, USA
Am J Med 115:134-42. 2003..Patients with medication-resistant tremor may benefit from thalamotomy or deep brain stimulation of the thalamus. The use of medical and surgical therapies can provide benefit in up to 80% of patients with essential tremor...
Bilateral thalamic stimulation for the treatment of essential tremorR Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City 66160, USA
Neurology 53:1447-50. 1999..To determine the safety and efficacy of bilateral thalamic stimulation in the treatment of essential tremor (ET)...
Options in the treatment of motor fluctuations and dyskinesias in Parkinson's disease: a brief reviewRajesh Pahwa
Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center, 3599 Rainbow Boulevard, Mailstop #2012, Kansas City, KS 66160, USA
Neurol Clin 22:S35-52. 2004
Long-term evaluation of deep brain stimulation of the thalamusRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Neurosurg 104:506-12. 2006..The aim of this study was to evaluate the long-term safety and efficacy of DBS of the ventralis intermedius nucleus (VIM) of the thalamus for PD and ET...
Quantitative assessments of the effect of bilateral subthalamic stimulation on multiple aspects of sensorimotor function for patients with Parkinson's diseaseW Liu
Department of Physical Therapy and Rehabilitation Sciences, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7601, USA
Parkinsonism Relat Disord 11:503-8. 2005..Future studies need to determine whether or not there is a potential negative effect of STN DBS on the postural control...
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts
Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama 35294 0017, USA
Mov Disord 25:858-66. 2010..Ropinirole prolonged-release delayed the onset of dyskinesia with comparable efficacy to increased doses of levodopa in early PD patients not optimally controlled with levodopa...
Long-term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremorW C Koller
Department of Neurology, University of Miami Medical Center, 1501 NW 9th Ave, Miami, FL 33136, USA
Mov Disord 16:464-8. 2001..However, this therapy is compromised by loss of efficacy in some patients and device complications which increase the risk of additional surgical procedures...
Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulationK Straits-Troster
Department of Veterans Affairs Medical Center, Kansas City, USA
Brain Cogn 42:399-416. 2000..Results suggest that neurosurgical interventions for PD improve disabling PD motor symptoms and also improve several domains of quality of life...
Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremorK E Lyons
University of Miami Medical Center, Department of Neurology, 1501 NW 9th Avenue, Miami, Florida 33136, USA
J Neurol Neurosurg Psychiatry 71:682-4. 2001..In conclusion, unilateral DBS of the thalamus has long term efficacy for treatment of tremor due to Parkinson's disease...
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuationsRobert A Hauser
Department of Neurology, University of South Florida, Tampa, Florida 33606, USA
Mov Disord 23:2177-85. 2008..We conclude that istradefylline is well tolerated and significantly reduces OFF time as an adjunct to levodopa in PD subjects with motor fluctuations...
Interactions between deep brain stimulation and levodopa in Parkinson's diseaseJ G Nutt
Department of Neurology, Oregon Health Sciences University, Portland 97201, USA
Neurology 57:1835-42. 2001..To quantify the effects of deep brain stimulation (DBS) of globus pallidus interna (GPi) and subthalamic nucleus (STN) on motor fluctuations and dyskinesia in PD and to determine how the response to levodopa was modified by DBS...
Magnitude of microelectrode refinement in pallidotomy and thalamotomyB D Milligan
Imaging Resource Center, University of Kansas Medical Center, Kansas City 66160, USA
Stereotact Funct Neurosurg 76:2-18. 2001..Lesions were consistently localized anterior and superior to the starting point and a refined starting point algorithm may reduce the number of microelectrode recording tracts...
Surgical treatment of Parkinson's diseaseW C Koller
Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7314, USA
J Neurol Sci 167:1-10. 1999..This procedure may control all PD symptoms, and the dose of levodopa can often be dramatically reduced. Neurotransplantation is a promising surgical approach to PD. However, further investigation is needed to optimize this approach...
Pharmacokinetic-pharmacodynamic crossover comparison of two levodopa extension strategiesPeter A LeWitt
Department of Neurology, Henry Ford Hospital and Wayne State University School of Medicine, Detroit, Michigan, USA
Mov Disord 24:1319-24. 2009..03). Despite less "off" time with CLE, both formulations demonstrated similar mean PK values and marked intersubject PK variability...
Bilateral subthalamic stimulation improves gait initiation in patients with Parkinson's diseaseW Liu
Department of Physical Therapy and Rehabilitation Sciences, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160 7601, USA
Gait Posture 23:492-8. 2006..It is concluded that DBS significantly improved the performance of patients with advanced PD in gait initiation...
Effects of bilateral subthalamic nucleus stimulation on sleep, daytime sleepiness, and early morning dystonia in patients with Parkinson diseaseKelly E Lyons
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Neurosurg 104:502-5. 2006....
Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopaKelly E Lyons
University of Kansas Medical Center, Department of Neurology, Kansas City, KS 66160, USA
Stereotact Funct Neurosurg 85:169-74. 2007..In conclusion, although levodopa responsiveness is the best predictor for outcome after STN DBS, carefully selected PD patients intolerant to levodopa can have significant improvement...
Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson diseaseKelly E Lyons
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Neurosurg 103:252-5. 2005....
Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyR Pahwa
University of Kansas Medical Center, Kansas City, USA
Neurology 66:983-95. 2006..5. Preoperative response to levodopa predicts better outcome after DBS of the STN (Level B)...
Use of brain MRI after deep brain stimulation hardware implantationJules M Nazzaro
Department of Neurosurgery, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Int J Neurosci 120:176-83. 2010..Rather, our data may contribute to further defining safe MRI scanning parameters that might ultimately be adopted in future product labeling as more centers report in detail their experiences...
An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's diseaseKelly E Lyons
Department of Neurology, Parkinson s Disease and Movement Disorder Center, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Mov Disord 24:2121-7. 2009..A conversion ratio of 1 mg of pramipexole to 4 mg of ropinirole PR resulted in the fewest discontinuations of ropinirole PR, the fewest dose adjustments and the largest percentage of subjects that preferred ropinirole PR...
Head positioning and risk of pneumocephalus, air embolism, and hemorrhage during subthalamic deep brain stimulation surgeryJules M Nazzaro
Department of Neurosurgery, University of Kansas Medical Center, Kansas City, 66160, USA
Acta Neurochir (Wien) 152:2047-52. 2010....
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effectsKelly E Lyons
University of Kansas Medical Center, Kansas City, KS 66160, USA
Clin Neuropharmacol 33:5-10. 2010....
Levodopa-related wearing-off in Parkinson's disease: identification and managementRajesh Pahwa
Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
Curr Med Res Opin 25:841-9. 2009..The initial complication is commonly wearing-off, which is the re-emergence of motor and non-motor symptoms before the next scheduled levodopa dose...
Surgical and hardware complications of subthalamic stimulation: a series of 160 proceduresKelly E Lyons
Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd, Mailstop 2012, Kansas City, KS 66160, USA
Neurology 63:612-6. 2004..To assess the surgical and hardware complications in a series of 81 consecutive patients undergoing subthalamic (STN) deep brain stimulation (DBS) for Parkinson disease (PD)...
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trialRobert G Holloway
Department of Neurology, University of Rochester, 1351 Mt Hope Avenue, Suite 220, Rochester, NY 14620, USA
Arch Neurol 61:1044-53. 2004..The best way to initiate dopaminergic therapy for early Parkinson disease remains unclear...
Pharmacotherapy of essential tremor : an overview of existing and upcoming agentsKelly E Lyons
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
CNS Drugs 22:1037-45. 2008..Several new drugs, including 1-octanol, sodium oxybate, dimethoxymethyl-diphenyl-barbituric acid (T-2000) and carisbamate, are currently under investigation for the treatment of essential tremor...
Open-label trial regarding the use of acupuncture and yin tui na in Parkinson's disease outpatients: a pilot study on efficacy, tolerability, and quality of lifeMarty L Eng
University of Kansas Medical Center, University of Kansas, School of Pharmacy, Department of Pharmacy Practice, Kansas City, KS 66160 7231, USA
J Altern Complement Med 12:395-9. 2006..This study evaluates the effects of sequential tui na massage, acupuncture, and instrument-delivered qigong for patients with Parkinson disease (PD) over a 6-month period...
Double-blind controlled study of methazolamide in the treatment of essential tremorK Busenbark
Department of Neurology, University of Kansas Medical Center, Kansas City 66160 7314
Neurology 43:1045-7. 1993..Side effects, paresthesias, sedation, headaches, and gastrointestinal symptoms were common. Only two patients elected to remain on the drug after the study. Methazolamide has only limited efficacy in the treatment of essential tremor...
Development and initial validation of a screening tool for Parkinson disease surgical candidatesM S Okun
Department of Neurology, University of Florida McKnight Brain Institute, 100 S Newell Dr, 3rd Fl, rm L3 100, PO Box 100236, Gainesville, FL 32610, USA
Neurology 63:161-3. 2004..Part II was a multicenter study to assess the correlation of FLASQ-PD scores. The results of this study suggest that the FLASQ-PD may be a useful triage tool for screening PD patients for DBS surgery...
Conversion from sustained release carbidopa/levodopa to carbidopa/levodopa/entacapone (stalevo) in Parkinson disease patientsKelly E Lyons
Department of Neurology, University of Kansas Medical Center, Kansas City, 66160, USA
Clin Neuropharmacol 29:73-6. 2006....
Treatment of early Parkinson's disease. Part 1Tanya Simuni
Department of Neurology, Northwestern University, Parkinson s Disease and Movement Disorders Center, Chicago, Ill 60611, USA
Eur Neurol 61:193-205. 2009..Safety and tolerability data are also reviewed. Part 2 of the article reviews key findings relevant to the assessment of potential neuroprotective therapies and the treatment of non-motor symptoms...
Levetiracetam is not effective for essential tremorRodger J Elble
Department of Neurology, Southern Illinois University School of Medicine, Springfield, IL 62794 9643, USA
Clin Neuropharmacol 30:350-6. 2007..To determine if levetiracetam is efficacious in the treatment of essential tremor...
Deep brain stimulation and essential tremorKelly E Lyons
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
J Clin Neurophysiol 21:2-5. 2004..Deep brain stimulation of the thalamus is a safe and efficacious procedure and should be considered in patients with ET who experience medication-resistant disabling tremor...
Benefits and risks of pharmacological treatments for essential tremorKelly E Lyons
University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Drug Saf 26:461-81. 2003..The use of medication and/or surgery can provide adequate tremor control in the majority of the patients...
Stimulation of the motor cortex for disabling essential tremorKelly E Lyons
Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd, Mailstop 2012, Kansas City, KS 66160, USA
Clin Neurol Neurosurg 108:564-7. 2006..To examine the safety and efficacy of targeted stimulation of the motor cortex as a treatment for essential tremor (ET)...
Freezing of gait after bilateral subthalamic nucleus stimulation for Parkinson's diseaseJustin T Davis
University of Kansas Medical Center, Department of Neurology, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
Clin Neurol Neurosurg 108:461-4. 2006..In the medication on state there were no significant improvements in freezing. CONCLUSION: Off period freezing of gait is significantly improved with STN DBS up to 24 months; however, on period freezing is not affected by STN DBS...
Treatment of early Parkinson's disease. Part 2Tanya Simuni
Department of Neurology, Northwestern University, Parkinson s Disease and Movement Disorders Center, Chicago, Ill, USA
Eur Neurol 61:206-15. 2009..Part 2 of the article, presented here, reviews key data relevant to the assessment of potential neuroprotective therapies and the treatment of non-motor symptoms...
Deep brain stimulation in Parkinson's diseaseKelly E Lyons
Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Boulevard, Mailstop 2012, Kansas City, KS 66160, USA
Curr Neurol Neurosci Rep 4:290-5. 2004..Complications associated with DBS are related to the experience of the surgical center. Referring physicians and patients should be aware of the number of surgical procedures and complication rates of any prospective surgical center...
Neuropathologic findings in essential tremorE D Louis
GH Sergievsky Center, Department of Neurology, Taub Institute for Research on Alzheimer s Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA
Neurology 66:1756-9. 2006..Six cases (60%) had Lewy bodies vs 2 controls (16.7%) (odds ratio 7.5, 95% CI 1.04 to 54.1; p = 0.035). Four of these six had an atypical distribution of brainstem Lewy bodies. ET may be pathologically heterogeneous...
Utility of the NeuroTrax computerized battery for cognitive screening in Parkinson's disease: comparison with the MMSE and the MoCAB Hanna-Pladdy
Landon Center on Aging, University of Kansas Medical Center, Kansas City, KS 66160, USA
Int J Neurosci 120:538-43. 2010..While the MoCA is sensitive, it may be too stringent in overclassifying PD patients as impaired...
Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseRodger J Elble
Department of Neurology, Southern Illinois University School of Medicine, Springfield, Illinois, USA
Mov Disord 25:1082-6. 2010..We found the investigators' level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment...
Early diagnosis of Parkinson's disease: recommendations from diagnostic clinical guidelinesRajesh Pahwa
University of Kansas Medical Center, 3599 Rainbow Blvd, Kansas City, KS 66160, USA
Am J Manag Care 16:S94-9. 2010..This article reviews and summarizes published recommendations for the clinical diagnosis of PD...
Postural tremor suppression is dependent on thalamic stimulation frequencyMwiza Ushe
Department of Neurology, Washington University, St. Louis, Missouri, USA
Mov Disord 21:1290-2. 2006....
A review of ropinirole prolonged release in Parkinson's diseaseMuhammad M Nashatizadeh
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Clin Interv Aging 4:179-86. 2009..This manuscript briefly reviews the current pharmacological treatment options for PD and provides a more detailed review of the currently available data regarding ropinirole prolonged release as a treatment option for PD...
Efficacy and tolerability of levetiracetam in Parkinson disease patients with levodopa-induced dyskinesiaKelly E Lyons
Department of Neurology, University of Kansas Medical Center, Kansas City, 66160, USA
Clin Neuropharmacol 29:148-53. 2006..This open-label study was performed to evaluate the efficacy and tolerability of levetiracetam for levodopa-induced dyskinesia and its effect on motor functioning and quality of life in Parkinson disease (PD) patients...
Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validationAlexander I Troster
Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC 27599 7025, USA
Parkinsonism Relat Disord 11:367-73. 2005..We sought to develop an ET-specific measure that might be more sensitive, acceptable to patients, relatively brief, and easily used...
Effect of stimulation frequency on tremor suppression in essential tremorMwiza Ushe
Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA
Mov Disord 19:1163-8. 2004..Second, thalamic DBS provides tremor benefit in a graded manner and is not an all-or-nothing phenomenon...
Long-term efficacy of globus pallidus stimulation for the treatment of Parkinson's diseaseKelly E Lyons
Department of Neurology, University of Miami Medical Center, Miami, Fla, USA
Stereotact Funct Neurosurg 79:214-20. 2002..To determine the long-term efficacy and safety of globus pallidus internus (GPi) stimulation for Parkinson's disease (PD)...
Maternal inheritance and mitochondrial DNA variants in familial Parkinson's diseaseDavid K Simon
Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
BMC Med Genet 11:53. 2010..We investigated the potential contribution of mtDNA variants or mutations to the risk of PD...
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's diseaseSteven R Schwid
Department of Neurology, University of Rochester, Rochester, New York, USA
Mov Disord 25:1801-8. 2010..Melanoma occurrence in our PD patients was greater than predicted compared with the general population and was unrelated to dopaminergic therapy. Clinical surveillance of PD patients for melanoma may be warranted...
Deep brain stimulation and tremorKelly E Lyons
Parkinson s Disease and Movement Disorder Center, Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Neurotherapeutics 5:331-8. 2008....
Electronic motor function diary for patients with Parkinson's disease: a feasibility studyKelly E Lyons
Parkinson s Disease and Movement Disorder Center, Department of Neurology, University of Kansas Medical Center, 3599 Rainbow Blvd, Mailstop 2012, Kansas City, KS 66160, USA
Parkinsonism Relat Disord 13:304-7. 2007..Electronic diaries could be operated by PD patients, provided valuable information about response patterns and resulted in average response compliance of approximately 1h...
Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatologyAlexander I Troster
Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
Stereotact Funct Neurosurg 80:43-7. 2003..Because depression is a potent correlate of QOL, and STN-DBS may be associated with changes in mood, this study sought to determine whether QOL improvement is a direct or indirect consequence of motor improvement...
Pulse width is associated with cognitive decline after thalamic stimulation for essential tremorSteven Paul Woods
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Box 356560, 1959 NE Pacific Street, Seattle, WA 98195-6560, USA
Parkinsonism Relat Disord 9:295-300. 2003..Findings indicate that although relatively higher PW settings might afford optimal tremor control in some patients, the corresponding risk of mild, probably often subclinical, cognitive morbidity must be weighed accordingly...
Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson diseaseWilliam B White
Division of Hypertension and Clinical Pharmacology, Pat and Jim Calhoun Cardiology Center and Clinical Trials Unit, University of Connecticut, Farmington, Connecticut 06030 3940, USA
Hypertension 52:587-93. 2008..3%, 2.6%, and 2.9% of the placebo, 0.5-mg, and 1.0-mg rasagiline groups, respectively. These data demonstrate that rasagiline did not induce postprandial hypertension in patients with Parkinson disease who were on an unrestricted diet...
Deep brain stimulation: preoperative issuesAnthony E Lang
Department of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada
Mov Disord 21:S171-96. 2006..It outlines answers to a series of questions developed to address all aspects of deep brain stimulation preoperative decision-making...
Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's diseaseMark F Lew
Keck University of Southern California School of Medicine, Los Angeles, CA 90033, USA
Curr Med Res Opin 23:741-50. 2007..This study assessed adjunctive Zelapar (selegiline orally disintegrating tablet (ODT)) for managing off episodes and for long-term safety...
Advanced Parkinson disease treated with rotigotine transdermal system: PREFER StudyPeter A LeWitt
Clinical Neuroscience Center, Southfield, MI 48034, USA
Neurology 68:1262-7. 2007..In patients experiencing motor fluctuations, a major treatment challenge is the reduction of "off" time, particularly upon awakening. Rotigotine (Neupro) is a novel dopaminergic agonist with 24-hour transdermal delivery...
Neuropathological changes in essential tremor: 33 cases compared with 21 controlsElan D Louis
GH Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, USA
Brain 130:3297-307. 2007..The majority have cerebellar changes without Lewy bodies; a smaller proportion has brainstem Lewy bodies. The clinical differences between cases with versus without Lewy bodies require additional study...
Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomesGalit Kleiner-Fisman
Parkinson s Disease Research Education and Clinical Center, Philadelphia VA Hospital, Philadelphia, Pennsylvania 19104, USA
Mov Disord 21:S290-304. 2006..These data provide an estimate of the magnitude of the treatment effects and emphasize the need for controlled and randomized studies...
Validity of clinical and patient ratings of tremor disability among older adultsDuane A Lundervold
Department of Psychology, Central Missouri State University, 1111 Lovinger Hall, Warrensburg, MO 64093, USA
Parkinsonism Relat Disord 10:15-8. 2003....
Association study of Parkin gene polymorphisms with idiopathic Parkinson diseaseSofia A Oliveira
Department of Medicine and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC
Arch Neurol 60:975-80. 2003..CONCLUSIONS: These results suggest that these common variants of Parkin are not associated with PD in white patients, although Parkin mutations are known to cause early- and late-onset PD...
Age at onset in two common neurodegenerative diseases is genetically controlledYi-Ju Li
Department of Medicine, Center for Human Genetics, Duke University Medical Center, Durham, NC 27710, USA
Am J Hum Genet 70:985-93. 2002..62. These data suggest that a common gene affects AAO in these two common complex neurodegenerative diseases...
Parkin mutations and susceptibility alleles in late-onset Parkinson's diseaseSofia A Oliveira
Department of Medicine and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
Ann Neurol 53:624-9. 2003..These findings suggest that mutations in Parkin contribute to the common form of PD and that heterozygous mutations, especially those lying in exon 7, act as susceptibility alleles for late-onset form of Parkinson disease...
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson diseaseYi Ju Li
Department of Medicine, Center for Human Genetics, Institute for Genome Science and Policy, Duke University Medical Center, Box 3445, Durham, NC 27710, USA
Hum Mol Genet 12:3259-67. 2003..This is provocative given reports of the possible role of inflammation in these two neurodegenerative disorders...
Mitochondrial polymorphisms significantly reduce the risk of Parkinson diseaseJoelle M van der Walt
Department of Medicine, and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
Am J Hum Genet 72:804-11. 2003..45; 95% CI 0.22-0.93; P=.03). Our results suggest that ND3 is an important factor in PD susceptibility among white individuals and could help explain the role of complex I in PD expression...
Bilateral pallidotomy for severe dystonia in an 18-month-old child with glutaric aciduriaGoran Rakocevic
National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA
Stereotact Funct Neurosurg 82:80-3. 2004..The surgery improved dystonic symptoms, especially pain in this child with minor complications related to the procedure. Pallidotomy is a reasonable option for children with dystonic symptoms secondary to glutaric aciduria...
Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease familiesLianna Ishihara
Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
Mov Disord 22:55-61. 2007....
Reduced Purkinje cell number in essential tremor: a postmortem studyJordan E Axelrad
Gertrude H Sergievsky Center, Columbia University, New York, New York, USA
Arch Neurol 65:101-7. 2008..In recent postmortem studies, we documented increased numbers of torpedoes (Purkinje cell axonal swellings) in ET patients without Lewy bodies. Purkinje cell loss, however, has never been rigorously assessed...
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's diseaseL Warren
Research and Development, GlaxoSmithKline Pharmaceuticals, Research Triangle Park, NC 27709, USA
Parkinsonism Relat Disord 14:77-80. 2008..The most recent common founder of the mutation was dated to 2600 (95% CI: 1950-3850) years ago although additional studies are warranted to ensure an accurate age estimate for this mutation...
Serum urate as a predictor of clinical and radiographic progression in Parkinson diseaseMichael A Schwarzschild
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Boston, USA
Arch Neurol 65:716-23. 2008..To determine whether concentration of serum urate, a purine metabolite and potent antioxidant that has been linked to a reduced risk of Parkinson disease (PD), predicts prognosis in PD...
Research Grants
- KU Center for Neuroprotection in Parkinson's DiseaseRajesh Pahwa; Fiscal Year: 2007..The University of Kansas Parkinson's Disease Center is willing and dedicated to adhere to a common protocol and to cooperate with other centers and NINDS in the conduct of both pilot studies and the main efficacy study. ..
